CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it will host a live webcast to present and discuss the newly disclosed, late-breaking 48-week Phase 3 clinical data in China for...

People

6 Energy-Saving Tips

Vietnam’s first-ever vegan wedding between a music icon and founder of...

Momcozy Launches SkinHug Mask-Feel Maternity Underwear: One-Size Comfort for Every Stage...

Scotlynn and Norfolk County Launch Rolling Billboards to Showcase Regional Strengths...

Clear View Building Services Publicizes Longstanding Commercial Cleaning Division

Global Pet Foods Celebrates National Pet Month with Pawsitively Canadian Campaign

Ollie’s Bargain Outlet Holdings, Inc. Announces First Quarter Fiscal 2025 Earnings...

Victoria’s Secret & Co. Adopts Limited-Duration Shareholder Rights Plan

Interior Painting Experts in Castle Rock Earn 5-Star Review for Quality...

HeyShape Reviews: Don’t Buy Hey Shape BodySuit Till You’ve Read This...

EKOUAER to Debut in Monaco as Exclusive VIP Gifting Partner Aboard...

Featured

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept...

6 Energy-Saving Tips

Saudia Unveils SV Lifestyle Brand at Riyadh Fashion Week

All Star Digital and Dart Co Launch One Hitters: Exclusive Partnership...

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept...